• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Covid-19: UK will offer third vaccine dose to severely immunosuppressed people.

作者信息

Wise Jacqui

机构信息

Kent.

出版信息

BMJ. 2021 Sep 2;374:n2160. doi: 10.1136/bmj.n2160.

DOI:10.1136/bmj.n2160
PMID:34475111
Abstract
摘要

相似文献

1
Covid-19: UK will offer third vaccine dose to severely immunosuppressed people.新冠疫情：英国将为严重免疫功能低下人群提供第三剂疫苗。
BMJ. 2021 Sep 2;374:n2160. doi: 10.1136/bmj.n2160.
2
The Impact of the COVID-19 Pandemic on the Uptake of Influenza Vaccine: UK-Wide Observational Study.COVID-19 大流行对流感疫苗接种率的影响：英国范围的观察性研究。
JMIR Public Health Surveill. 2021 Apr 14;7(4):e26734. doi: 10.2196/26734.
3
Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.在新冠疫情期间使用卡介苗增强医护人员的非特异性防护：丹麦一项随机对照试验研究方案的结构化总结
Trials. 2020 Sep 17;21(1):799. doi: 10.1186/s13063-020-04714-3.
4
COVID-19 Vaccine: A neutrosophic MCDM approach for determining the priority groups.新冠疫苗：一种用于确定优先接种群体的中性多准则决策方法
Results Phys. 2021 Jan;20:103654. doi: 10.1016/j.rinp.2020.103654. Epub 2020 Dec 10.
5
COVID-19 vaccines - are we there yet?新冠疫苗——我们成功了吗？
Aust Prescr. 2021 Feb;44(1):19-25. doi: 10.18773/austprescr.2020.084. Epub 2020 Dec 17.
6
Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vaccine.在英国，对2、3、4月龄婴儿进行三剂次基础疫苗接种程序，接种含无细胞百日咳成分的白喉、破伤风、百日咳、b型流感嗜血杆菌联合疫苗时，接种一剂、两剂或三剂与破伤风类毒素结合的C群脑膜炎球菌结合疫苗后的免疫原性。
Vaccine. 2006 Jan 12;24(2):215-9. doi: 10.1016/j.vaccine.2005.07.060. Epub 2005 Aug 8.
7
Covid-19: Third candidate vaccine will be tested in UK.
BMJ. 2020 Nov 16;371:m4451. doi: 10.1136/bmj.m4451.
8
Immunocompromised patients in the USA and UK should receive third dose of COVID-19 vaccine.美国和英国的免疫功能低下患者应接种第三剂新冠疫苗。
Lancet Rheumatol. 2021 Nov;3(11):e756. doi: 10.1016/S2665-9913(21)00313-1. Epub 2021 Sep 27.
9
BCG Vaccine does not Protect Against COVID-19.卡介苗不能预防新冠病毒。
Open Respir Med J. 2020 Nov 26;14:45-46. doi: 10.2174/1874306402014010045. eCollection 2020.
10
Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis.在一项基于英国观察队列分析的研究中，意外给予免疫抑制个体水痘带状疱疹活疫苗的安全性。
BMJ Open. 2020 Jan 29;10(1):e034886. doi: 10.1136/bmjopen-2019-034886.

引用本文的文献

1
A Descriptive Evaluation of Health Literacy and Determinants of COVID-19 Vaccine Acceptance among Patients with IgA Nephropathy with High Vaccine Uptake.对疫苗接种率高的IgA肾病患者的健康素养及新冠病毒疫苗接受度决定因素的描述性评估
Glomerular Dis. 2022 Jan 24;2(3):132-138. doi: 10.1159/000522158. eCollection 2022 Jul.
2
Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis.HIV 感染者的 COVID-19 疫苗免疫原性和疗效：系统评价和荟萃分析。
Int J Infect Dis. 2022 Nov;124:212-223. doi: 10.1016/j.ijid.2022.10.005. Epub 2022 Oct 12.
3
Expected cost effectiveness of the fourth dose of COVID-19 vaccine against the omicron variant of COVID-19: a preliminary report.
新冠病毒奥密克戎变异株第四剂新冠疫苗的预期成本效益：初步报告
Int J Physiol Pathophysiol Pharmacol. 2022 Aug 15;14(4):272-275. eCollection 2022.
4
Strategies and safety considerations of booster vaccination in COVID-19.COVID-19 加强针接种的策略和安全性考虑。
Bosn J Basic Med Sci. 2022 Jun 1;22(3):366-373. doi: 10.17305/bjbms.2021.7082.
5
Expected response to the additional third dose of COVID-19 vaccine based on different complete standard vaccination background.基于不同完整标准疫苗接种背景下对额外第三剂新冠疫苗的预期反应。
Int J Physiol Pathophysiol Pharmacol. 2022 Feb 15;14(1):1-3. eCollection 2022.
6
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.新冠疫苗在免疫功能低下患者中的有效性：系统评价和荟萃分析。
BMJ. 2022 Mar 2;376:e068632. doi: 10.1136/bmj-2021-068632.
7
A case of herpes zoster ophthalmicus after third dose of Comirnaty (BNT162b2 mRNA) vaccine.第三剂辉瑞-BioNTech新冠疫苗（BNT162b2 mRNA）接种后发生的1例眼部带状疱疹。
Dermatol Ther. 2022 May;35(5):e15411. doi: 10.1111/dth.15411. Epub 2022 Mar 4.
8
Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients-Is It Related to Immunosuppression Only?SARS-CoV-2 BNT162b2疫苗在肝移植受者与肾移植受者中疗效意外高——这仅与免疫抑制有关吗？
Vaccines (Basel). 2021 Dec 8;9(12):1454. doi: 10.3390/vaccines9121454.
9
What Happens to the Immune System after Vaccination or Recovery from COVID-19?接种疫苗或从新冠病毒感染中康复后免疫系统会发生什么？
Life (Basel). 2021 Oct 29;11(11):1152. doi: 10.3390/life11111152.
10
Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者 COVID-19 疫苗失败的原因和后果。
Eur J Haematol. 2022 Feb;108(2):91-98. doi: 10.1111/ejh.13722. Epub 2021 Dec 5.